Gaush Meditech Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG3902N1051
HKD
8.75
-0.31 (-3.42%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,553.89
1,458.00
1,564.63
1,081.08
1,254.85
1,097.50
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,553.89
1,458.00
1,564.63
1,081.08
1,254.85
1,097.50
Raw Material Cost
789.67
730.81
854.30
603.13
743.04
662.11
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
389.50
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
55.92
49.63
101.21
12.84
4.48
4.06
Selling and Distribution Expenses
417.92
384.71
368.73
261.41
303.98
300.73
Other Expenses
-38.70
-0.19
-7.29
-0.93
-0.15
-0.13
Total Expenditure (Excl Depreciation)
1,266.03
1,163.30
1,251.36
868.06
1,050.03
965.63
Operating Profit (PBDIT) excl Other Income
287.9
294.7
313.29999999999995
213
204.8
131.9
Other Income
37.93
-202.71
84.18
40.19
-0.35
-4.76
Operating Profit (PBDIT)
409.73
163.68
460.36
267.05
217.82
139.00
Interest
55.92
49.63
101.21
12.84
4.48
4.06
Exceptional Items
3.88
-357.49
-453.04
-72.75
-196.04
-135.24
Gross Profit (PBDT)
764.22
727.19
710.33
477.95
511.81
435.39
Depreciation
83.94
76.46
72.38
13.86
14.87
14.48
Profit Before Tax
273.75
-319.90
-166.28
167.60
2.44
-14.79
Tax
82.68
90.26
64.61
56.88
45.56
30.93
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
191.74
-406.56
-229.53
111.66
-42.00
-44.29
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
191.74
-406.56
-229.53
111.66
-42.00
-44.29
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.67
-3.60
-1.35
-0.93
-1.12
-1.44
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
191.07
-410.16
-230.88
110.73
-43.12
-45.73
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,850.20
1,649.93
-802.99
30.38
-90.98
27.42
Earnings per share (EPS)
1.3
-4.19
-2.39
1.06
-0.39
-0.4
Diluted Earnings per share
1.3
-4.19
-2.39
1.06
-0.39
-0.4
Operating Profit Margin (Excl OI)
18.52%
19.89%
19.42%
19.7%
16.2%
11.78%
Gross Profit Margin
23.02%
-16.7%
-6.0%
16.79%
1.38%
-0.03%
PAT Margin
12.34%
-27.89%
-14.67%
10.33%
-3.35%
-4.04%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2023 is 6.58% vs -6.81% in Dec 2022

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2023 is 146.59% vs -77.65% in Dec 2022

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2023 is 1.47% vs -2.60% in Dec 2022

stock-summary

Interest

YoY Growth in year ended Dec 2023 is 12.70% vs -50.99% in Dec 2022

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2023 has fallen from Dec 2022

Compare Annual Results Of Gaush Meditech Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
1,553.89
1,204.60
349.29
29.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,553.89
1,204.60
349.29
29.00%
Raw Material Cost
789.67
370.83
418.84
112.95%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
389.50
0.00
389.50
Power Cost
0
0
0.00
Manufacturing Expenses
55.92
1.11
54.81
4,937.84%
Selling and Distribution Expenses
417.92
429.76
-11.84
-2.76%
Other Expenses
-38.70
11.15
-49.85
-447.09%
Total Expenditure (Excl Depreciation)
1,266.03
913.17
352.86
38.64%
Operating Profit (PBDIT) excl Other Income
287.86
291.43
-3.57
-1.22%
Other Income
37.93
97.04
-59.11
-60.91%
Operating Profit (PBDIT)
409.73
421.39
-11.66
-2.77%
Interest
55.92
1.11
54.81
4,937.84%
Exceptional Items
3.88
7.71
-3.83
-49.68%
Gross Profit (PBDT)
764.22
833.77
-69.55
-8.34%
Depreciation
83.94
32.92
51.02
154.98%
Profit Before Tax
273.75
395.07
-121.32
-30.71%
Tax
82.68
35.66
47.02
131.86%
Provisions and contingencies
0
0
0.00
Profit After Tax
191.74
352.87
-161.13
-45.66%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
191.74
352.87
-161.13
-45.66%
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.67
0.00
-0.67
Other related items
0.00
0.00
0.00
Consolidated Net Profit
191.07
352.87
-161.80
-45.85%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,850.20
2,884.62
-1,034.42
-35.86%
Earnings per share (EPS)
1.30
0.42
0.88
209.52%
Diluted Earnings per share
1.30
0.42
0.88
209.52%
Operating Profit Margin (Excl OI)
18.52%
24.19%
0.00
-5.67%
Gross Profit Margin
23.02%
35.53%
0.00
-12.51%
PAT Margin
12.34%
29.29%
0.00
-16.95%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 155.39 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 6.58% vs -6.81% in Dec 2022

Annual - Consolidate Net Profit
Consolidate Net Profit 19.11 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 146.59% vs -77.65% in Dec 2022

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 37.18 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 1.47% vs -2.60% in Dec 2022

Annual - Interest
Interest 5.59 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 12.70% vs -50.99% in Dec 2022

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.52%
in Dec 2023

Figures in %
stock-summary

YoY Growth in year ended Dec 2023 has fallen from Dec 2022